ICH Project ICH S1B (R1): Briefing on the draft guideline "Addendum to the Guideline on Testing for Carcinogenicity of Pharmaceuticals" which reached Step 2

July 28, 2021

ICH S1B(R1) "Addendum to the Guidelines on Testing for Carcinogenicity of Pharmaceuticals" has reached Step 2, and a briefing session was held jointly by Japan Pharmaceutical Manufacturers Association, Ministry of Health, Labour and Welfare, and Pharmaceuticals and Medical Devices Agency (PMDA).